BCEL logo

Atreca Inc



- $0.02 (-7.14%) This month

Closed: 29 Feb 2024 21:00 US/Eastern

Key details


John Orwin




South San Francisco, US




Pharmaceutical Preparation Manufacturing

About Atreca Inc

atreca is a biotechnology company that develops novel therapeutics through a deep understanding of the human immune response, with a focus on innovative novel cancer immunotherapeutics. with its immune repertoire capture™ (irc™) technology, atreca has an unparalleled insight into how cancer patients’ immune responses can drive better clinical outcomes. atreca was founded by scientists, industry experts, and investors who share the vision that unlocking the immune response of today’s patients is the key to creating a new generation of therapies. atreca is looking for talented, entrepreneurial people who are dedicated to making a positive impact on human health. if you are interested in becoming part of the atreca team, our open positions can be found at: http://www.atreca.com/careers/

Please treat this data as an indicator only since we can't always guarantee that it's accurate or complete. Bear in mind too that the prices you'll see are delayed by at least 15 minutes. Intraday pricing and company data provided by IEX.
© Finimize Ltd. 2023. 10328011. 280 Bishopsgate, London, EC2M 4AG